Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab + Adriamycin in Advanced Soft Tissue Sarcoma
NCT06367075Phase 2Recruiting
- Start
- Oct 2024
- Primary completion
- Mar 2027
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cadonilimab in soft tissue sarcoma (STS). Started Oct 2024; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT06367075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367075.